MXPA00012560A - Uso de interleucocina-11 para tratar desordenes gastrointestinales. - Google Patents

Uso de interleucocina-11 para tratar desordenes gastrointestinales.

Info

Publication number
MXPA00012560A
MXPA00012560A MXPA00012560A MXPA00012560A MXPA00012560A MX PA00012560 A MXPA00012560 A MX PA00012560A MX PA00012560 A MXPA00012560 A MX PA00012560A MX PA00012560 A MXPA00012560 A MX PA00012560A MX PA00012560 A MXPA00012560 A MX PA00012560A
Authority
MX
Mexico
Prior art keywords
interleukin
gastrointestinal disorders
treat gastrointestinal
treat
disorders
Prior art date
Application number
MXPA00012560A
Other languages
English (en)
Inventor
C Keith James
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Publication of MXPA00012560A publication Critical patent/MXPA00012560A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2073IL-11
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA00012560A 1999-04-15 2000-04-07 Uso de interleucocina-11 para tratar desordenes gastrointestinales. MXPA00012560A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12942199P 1999-04-15 1999-04-15
US54562700A 2000-04-07 2000-04-07
PCT/US2000/009256 WO2001007076A1 (en) 1999-04-15 2000-04-07 Use of interleukin-11 to treat gastrointestinal disorders

Publications (1)

Publication Number Publication Date
MXPA00012560A true MXPA00012560A (es) 2003-08-20

Family

ID=26827556

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA00012560A MXPA00012560A (es) 1999-04-15 2000-04-07 Uso de interleucocina-11 para tratar desordenes gastrointestinales.

Country Status (7)

Country Link
US (2) US6723314B2 (es)
EP (1) EP1096948A4 (es)
JP (1) JP2003505429A (es)
AU (1) AU781459B2 (es)
CA (1) CA2345920A1 (es)
MX (1) MXPA00012560A (es)
WO (1) WO2001007076A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377906B2 (en) * 2004-06-04 2013-02-19 Ethicon, Inc. Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
US20070141156A1 (en) * 2005-12-21 2007-06-21 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
US8129359B2 (en) 2004-06-04 2012-03-06 Ethicon, Inc. Composition and method for treating post-surgical pain
US20080069796A1 (en) * 2006-07-31 2008-03-20 Kim Jong-Mook Low Dose Treatment with an Interleukin-11 Analog

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215895A (en) 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
US5292646A (en) 1991-02-06 1994-03-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5270181A (en) 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5460810A (en) * 1992-09-02 1995-10-24 Genetics Institute, Inc. Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11
US5679339A (en) 1995-06-27 1997-10-21 Keith; James Method of using IL-11 for treating spondyloarthropies
US6126933A (en) * 1995-06-27 2000-10-03 Genetics Institute Methods of treating inflammatory bowel diseases by administering IL-11

Also Published As

Publication number Publication date
US20040161406A1 (en) 2004-08-19
EP1096948A4 (en) 2004-04-07
US6723314B2 (en) 2004-04-20
AU4332900A (en) 2001-02-13
EP1096948A1 (en) 2001-05-09
CA2345920A1 (en) 2001-02-01
WO2001007076A1 (en) 2001-02-01
JP2003505429A (ja) 2003-02-12
US20010046482A1 (en) 2001-11-29
AU781459B2 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
GB0007193D0 (en) Treatment of movrmrnt disorders
HK1161893A1 (zh) 煤炭加工
HUP0400914A3 (en) Methods of treatment of mitochondrial disorders
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
PL352030A1 (en) Treatment to neurotic disorders
HK1051485A1 (zh) 增生性疾病的治療
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
GB9926968D0 (en) Treatment of neurological disorders
ZA200110436B (en) Therapeutic use of melatonin.
MXPA00012560A (es) Uso de interleucocina-11 para tratar desordenes gastrointestinales.
AU8609201A (en) Reduction of the electrocardiographic ot interval
AU4838301A (en) Treatment of disorders relating to the serotonergic system
GB0010496D0 (en) Treatment of conditions of the central nervous system
AU3582101A (en) The treatment of functional gastrointestinal disorders
GB9911238D0 (en) Therapeutic use
GB0004998D0 (en) The treatment of functional gastrointestinal disorders
IL153788A0 (en) Treatment of eating disorders using carboxyalkylethers
GB9924942D0 (en) Treatment of movement disorders
GB0021060D0 (en) Treatment of functional gastrointestinal disorders
GB9926206D0 (en) Anti-snoring treatment
GB9919565D0 (en) Treatment of disease
GB0003228D0 (en) Treatment of GI disorders
GB9924980D0 (en) Therapeutic treatment
GB9901505D0 (en) Therapeutic treatment

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration